Home/Filings/4/0000950170-25-027280
4//SEC Filing

Tate Leah 4

Accession 0000950170-25-027280

CIK 0000913142other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 9:51 PM ET

Size

27.2 KB

Accession

0000950170-25-027280

Insider Transaction Report

Form 4
Period: 2025-02-21
Tate Leah
SVP - HR
Transactions
  • Sale

    Common Stock

    2025-02-25$111.76/sh164$18,32922,567 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2025-02-244410 total
    Exercise: $53.79From: 2023-02-22Exp: 2032-02-22Common Stock (441 underlying)
  • Tax Payment

    Common Stock

    2025-02-2143522,808 total
  • Exercise/Conversion

    Common Stock

    2025-02-24$53.79/sh+441$23,72123,008 total
  • Tax Payment

    Common Stock

    2025-02-2424122,567 total
  • Disposition to Issuer

    Common Stock

    2025-02-24$111.09/sh277$30,77222,731 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,030.108
  • Common Stock

    (indirect: By Spouse)
    3,360
Footnotes (6)
  • [F1]Shares withheld for tax purposes related to portion of February 21, 2024 restricted stock unit grant that vested on February 21, 2025.
  • [F2]Shares withheld for tax purposes related to February 22, 2022 restricted stock unit grant that vested on February 24, 2025.
  • [F3]Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.
  • [F4]The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Tate on November 8, 2024.
  • [F5]This represents the difference between the number of SARs exercised (441) and the number of shares issued as a result of the exercise (164). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($111.09) and the exercise price ($53.79). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
  • [F6]The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Tate on November 8, 2024.

Issuer

BELDEN INC.

CIK 0000913142

Entity typeother

Related Parties

1
  • filerCIK 0001916589

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 9:51 PM ET
Size
27.2 KB